血小板凝集设备市场规模、份额及成长分析（按产品、应用、最终用户和地区）－2025-2032 年产业预测

2023 年全球血小板凝集设备市场规模为 5.5291 亿美元，预计将从 2024 年的 5.9051 亿美元成长到 2032 年的 9.9953 亿美元，预测期内（2025-2032 年）的复合年增长率为 6.8%。

由于目标疾病盛行率上升和老年人口成长，全球市场正在经历强劲成长。此外，血小板凝集检测（对于检测血小板功能和相关疾病至关重要）的技术创新也在推动市场发展。此外，临床研究和产学合作的快速增加也推动着技术创新和市场扩张。然而，医疗保健程序限制、美国医疗保健体系改革不利以及熟练专业人员短缺等挑战可能会阻碍这一成长轨迹。总体而言，市场前景依然乐观，但应对这些挑战对于维持长期成长至关重要。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局

血小板凝集设备市场规模（依产品及复合年增长率）（2025-2032）

• 市场概览
• 系统
• 试剂
• 耗材及配件

血小板凝集设备市场规模（依应用）及复合年增长率（2025-2032）

• 市场概览
• 临床应用
• 研究用途

血小板凝集设备市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概览
• 医院和诊所
• 诊断实验室
• 研究和学术机构
• 其他的

血小板凝集设备市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• F. Hoffmann-La Roche Ltd.（Switzerland）
• Siemens Healthineers AG（Germany）
• Haemonetics Corporation（USA）
• Sysmex Corporation（Japan）
• Helena Laboratories Corporation（USA）
• Chrono-Log Corporation（USA）
• Drucker Diagnostics（USA）
• Werfen（Spain）
• Aggredyne, Inc.（USA）
• Sentinel CH. SpA（Italy）
• Tem Group（Germany）
• LSI Medience Corporation（Japan）
• Matis Medical Inc.（USA）
• Hart Biologicals（UK）

结论和建议

Global Platelet Aggregation Devices Market size was valued at USD 552.91 million in 2023 and is poised to grow from USD 590.51 million in 2024 to USD 999.53 million by 2032, growing at a CAGR of 6.8% during the forecast period (2025-2032).

The global market is witnessing robust growth, fueled by the rising prevalence of targeted diseases and a growing geriatric population. Technological innovations in platelet aggregometry, critical for examining platelet function and associated disorders, are also enhancing market momentum. Furthermore, an increase in collaborations between industry and academia, along with a surge in clinical studies, is driving innovation and market expansion. However, challenges such as procedural constraints in healthcare, adverse reforms within the U.S. healthcare system, and a shortage of skilled professionals may hinder this growth trajectory. Overall, while the market outlook remains positive, addressing these challenges will be crucial for sustaining growth in the long term.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Platelet Aggregation Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Platelet Aggregation Devices Market Segments Analysis

Global Platelet Aggregation Devices Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Systems, Reagents and Consumables and Accessories. Based on Application, the market is segmented into Clinical Applications and Research Applications. Based on End User, the market is segmented into Hospitals and Clinics, Diagnostic Laboratories, Research and Academic Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Platelet Aggregation Devices Market

The global platelet aggregation devices market is poised for significant growth driven by the rising demand for these essential diagnostic tools. This surge is largely influenced by the increasing incidence of chronic diseases and bleeding disorders worldwide, which necessitate effective monitoring and management solutions. As the prevalence of such medical conditions escalates, the need for advanced diagnostic capabilities becomes critical, with platelet aggregation devices at the forefront of this evolution. These devices are vital for evaluating platelet function, thereby facilitating the diagnosis and treatment of various coagulation-related disorders. This growing reliance on advanced technology is expected to create ample opportunities for market stakeholders.

Restraints in the Global Platelet Aggregation Devices Market

The growth of the global platelet aggregation devices market is hindered by several significant challenges, primarily the high costs associated with these advanced diagnostic tools and a shortage of qualified personnel. The considerable investment required to purchase platelet aggregation devices can deter healthcare organizations and facilities from incorporating them into their operations, limiting access to these technology-driven solutions. Additionally, the lack of trained staff hampers the effective usage and maintenance of the devices, further exacerbating the situation. Consequently, these factors collectively restrain the expansion of the market and the widespread adoption of essential platelet aggregation technologies.

Market Trends of the Global Platelet Aggregation Devices Market

The Global Platelet Aggregation Devices market is witnessing a significant upward trend, spurred by the increasing incidence of hemostasis disorders worldwide. As healthcare professionals emphasize the importance of accurate platelet aggregation testing for diagnosing various bleeding and coagulation disorders, the demand for these specialized devices is rapidly expanding. The growing awareness of the critical role that platelet function plays in therapeutic monitoring and clinical decision-making is further fueling market growth. Moreover, advancements in technology and the development of user-friendly, highly sensitive devices are enhancing their clinical utility. As hemostatic issues become more prevalent, the platelet aggregation devices market is projected to see sustained growth through the forecast period, underscoring its vital role in modern healthcare diagnostics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Platelet Aggregation Devices Market Size by Product & CAGR (2025-2032)

• Market Overview
• Systems
• Reagents
• Consumables and Accessories

Global Platelet Aggregation Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Clinical Applications
• Research Applications

Global Platelet Aggregation Devices Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Diagnostic Laboratories
• Research and Academic Institutes
• Others

Global Platelet Aggregation Devices Market Size & CAGR (2025-2032)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemonetics Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helena Laboratories Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chrono-Log Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Drucker Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Werfen (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aggredyne, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sentinel CH. SpA (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tem Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LSI Medience Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Matis Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hart Biologicals (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations